Product Candidates


Adherex Technologies has three products in advanced clinical development, each representing a major therapeutic opportunity for cancer patients and significant commercial opportunity for our company.
 
•         Eniluracil
•         ADH-1
•         STS

 

 

See Clinical Trials Factsheet